A model to predict red blood cell transfusion during/after cesarean delivery
Pregnancy · 2026-03 · 2 (2)
DOI: 10.1002/pmf2.70249 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pregnancy, online erschienen am 24.02.2026. Verfasst von Samuel Parry und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, Eunice Kennedy Shriver National Institute of Child Health and Human Development.
Abstract (Originalsprache)
Background
Cesarean delivery is a major risk factor for postpartum hemorrhage. A priority for postpartum hemorrhage safety bundles is the assessment of hemorrhage and transfusion risk following cesarean delivery and the identification of patients at increased risk for postpartum hemorrhage requiring red blood cell transfusion. A prediction model based on antenatal and intrapartum risk factors could be used in a standardized manner among all patients when considering crossmatch or other preparatory measures prior to cesarean delivery.
Objective
To develop a multivariable prediction model for red blood cell transfusion associated with cesarean delivery using a prospective contemporary cohort.
Methods
Secondary analysis of a multicenter trial of tranexamic acid (TXA) versus placebo for the prevention of red blood cell transfusion after cesarean delivery was performed. The primary outcome for this analysis was transfusion of packed red blood cells by hospital discharge or 7 days postpartum, whichever came first. Maternal characteristics and risk factors related to labor were compared between patients who received a transfusion and those who did not. Any of the characteristics that differed with a p value
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Department of Epidemiology, The George Washington University Biostatistics Center, Washington, District of Columbia, USA.
- Department of Obstetrics and Gynecology, The University of Texas Medical Branch, Galveston, Texas, USA.
- Department of Obstetrics and Gynecology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
- The Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland, USA.
- Department of Obstetrics and Gynecology, Case Western Reserve University, Cleveland, Ohio, USA.
ORCID-Profile: Kara Rood, Jennifer L Bailit
Förderung
- NICHD NIH HHS
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
Zitieren
APA
Parry, S., Weiner, S. J., Saade, G. R., Clifton, R. G., Thorp, J. M., Longo, M., Salazar, A., Dalton, W., Tita, A. T. N., Gyamfi-Bannerman, C., Chauhan, S. P., Metz, T. D., Rood, K., Rouse, D. J., Bailit, J. L., Grobman, W. A., Simhan, H. N., Macones, G. A., & Pacheco, L. D. (2026). A model to predict red blood cell transfusion during/after cesarean delivery. Pregnancy, 2(2). https://doi.org/10.1002/pmf2.70249
Vancouver
Parry S, Weiner SJ, Saade GR, Clifton RG, Thorp JM, Longo M, et al. A model to predict red blood cell transfusion during/after cesarean delivery. Pregnancy. 2026;2(2). doi:10.1002/pmf2.70249
BibTeX
@article{Parry2026,
author = {Parry, Samuel and Weiner, Steven J and Saade, George R and Clifton, Rebecca G and Thorp, John M and Longo, Monica and Salazar, Ashley and Dalton, Wendy and Tita, Alan T N and Gyamfi-Bannerman, Cynthia and Chauhan, Suneet P and Metz, Torri D and Rood, Kara and Rouse, Dwight J and Bailit, Jennifer L and Grobman, William A and Simhan, Hyagriv N and Macones, George A and Pacheco, Luis D},
title = {A model to predict red blood cell transfusion during/after cesarean delivery},
journal = {Pregnancy},
year = {2026},
volume = {2},
number = {2},
doi = {10.1002/pmf2.70249}
}
EUVIMED